EMED Announces US Market Clearance for VersaRate® Flow Regulator
EMED Technologies today announced US market clearance for the VersaRate® Flow Regulator, a variable flow rate device for subcutaneous infusion therapy.
VersaRate® obtained FDA clearance in December of 2012 and European and Canadian authorization in April of 2013, enabling broad commercial availability across major markets.
The device provides a practical, intuitive solution for adjusting infusion rates when more advanced pumps may not be available. Its straightforward design, proven reliability, and adaptability have made it a preferred choice in both clinical and home settings — particularly for patients with Primary Immunodeficiency (PIDD, CIDP) and other conditions requiring regular infusions. VersaRate® allows the patient to easily control flow rate with the turn of a dial.
The clearance underscores EMED's leadership in flow control technologies and the Company's commitment to delivering accessible, patient-centric infusion solutions worldwide.
For more information about VersaRate® and EMED's full portfolio, visit emedtc.com.
About EMED
EMED Technologies is an industry leader in the design, manufacture, and distribution of cutting-edge medical devices. For two decades, EMED Technologies has worked with clinicians, inventors, and medical companies to develop innovative medical products. Today, we are proud that both patients and clinicians can benefit from the fruits of our labor because we offer a wide variety of products and services that improve therapies and enhance clinical benefits. With our dynamic team of professionals, EMED continues to work with clinicians to understand their requirements and improve upon available technologies. In addition to novel technology, EMED is proud to offer licensing agreements for patented and proprietary technologies.
Media contact
For media inquiries, please contact info@emedtc.com.